Labwire, Inc. (LBWR) Research
Labwire, Inc., operating alongside its subsidiary Workplace Screening Services, specializes in delivering comprehensive employee screening solutions to Fortune 500 corporations across the United States. The company primarily leverages its proprietary Labwire Platform, a web-based application designed to streamline the intricate regulatory and record management processes inherent in employee screening. Their service portfolio encompasses drug testing, thorough employee background checks, expert analysis and updates for drug testing policies, medical reviews, and targeted supervisor training and education programs. Additionally, Labwire offers real-time online data management, assists with Red Flag Compliance initiatives, and develops robust drug testing programs. Key functionalities of the Labwire application itself include seamless data management and transmission, efficient collection site administration with consolidated billing, and the generation of custom statistical reports and data transfers. Furthermore, Labwire, Inc. extends tailor-made assistance to organizations, including educational resources, dedicated client support systems, detailed background investigations, physical examinations, and a range of other bespoke services. Established in 2004, Labwire, Inc. maintains its headquarters in Brookshire, Texas.
Market snapshot
- Symbol
- LBWR
- Price
- $0.00
- Day change
- 0.00%
- Market cap
- $59.1K
- P/E ratio
- -2939.63x
- 52-week range
- 0.0001-0.0004
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
Open Labwire, Inc. (LBWR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.